Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.
about
Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trendsClinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThe Role of Central Neck Lymph Node Dissection in the Management of Papillary Thyroid CancerPrediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study.Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery CentersKnowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.Predictors of Regional Lymph Node Recurrence after Initial Thyroidectomy in Patients with Thyroid Cancer.Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection.Preferential Use of Total Thyroidectomy without Prophylactic Central Lymph Node Dissection for Early-Stage Papillary Thyroid Cancer: Oncologic Outcomes in an Integrated Health Plan.To Identify Predictors of Central Lymph Node Metastasis in Patients with Clinically Node-Negative Conventional Papillary Thyroid Carcinoma.Radioguided sentinel lymph node biopsy in patients with papillary thyroid carcinoma.The Effect of Prophylactic Central Neck Dissection on Locoregional Recurrence in Papillary Thyroid Cancer After Total Thyroidectomy: A Systematic Review and Meta-Analysis : pCND for the Locoregional Recurrence of Papillary Thyroid Cancer.Surgical management of papillary thyroid carcinoma: an overview.Surgical considerations for papillary thyroid microcarcinomas.Surgical approach to level VI in papillary thyroid carcinoma: an overview.Response to Treatment is Highly Predictable in cN0 Patients with Papillary Thyroid Carcinoma.Incidental parathyroidectomy during thyroidectomy increases the risk of postoperative hypocalcemia.Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients.Prophylactic "First-Step" Central Neck Dissection (Level 6) Does Not Increase Morbidity After (Total) Thyroidectomy.Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis.MIVAT: the last 2 years experience, tips and techniques after more than 10 years.Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.Recent advances in managing differentiated thyroid cancer.Role of prophylactic central neck dissection in clinically node-negative differentiated thyroid cancer: assessment of the risk of regional recurrence.Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.Follicular cell-derived thyroid cancer.Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.BRAF testing and thyroid FNA.The extent of surgery in thyroglossal cyst carcinoma.Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching
P2860
Q26749311-88DC92E4-7106-4FAA-AF9F-EF0743BF8F52Q28077406-28FCC463-27E9-460B-B31E-C061C1405CD2Q30367068-D19D6024-44CB-4059-AEB7-A75B0C54676DQ33810411-D4782423-1A8D-477B-96DA-7C6EA2371391Q35912663-2E34497F-D679-45C1-9660-01264405A6C1Q36786213-866C841F-A64D-4736-A4D9-2615197B544BQ36936147-0423E736-2224-4E73-B005-BCEDAA188F34Q37043987-AFCCECD5-5980-45AE-9D76-28E8D06D4130Q37279358-E56AF592-2BE9-4CDD-A361-5C84035580DEQ37374637-EF054461-8D83-4B4E-AF15-E6A286F94C42Q37401945-FD1418C4-4011-4157-9B8A-762D2F6B0E94Q37542581-F7BF284D-A967-4415-912E-AA1B371E4169Q37584336-E7AC1EE5-53FA-46CD-9910-A33134919D45Q39028145-A66725F8-48FF-4AA3-B926-8D9DCB0A8A21Q39239856-503A1DEF-CFD8-4F29-B8E5-1FBE1C29BE78Q39312867-28C01DF2-16E6-4DDC-9ECF-16A0530F7288Q39371366-F037847B-03BC-42C2-8E12-A31686FF771AQ39838749-3C49890C-5D3A-4046-9065-59B646899E5AQ40365300-2E172470-3F39-4D4F-8282-C3170D75FE4CQ41110379-5BBDE293-A9B5-4302-814C-9D627A729236Q41288073-F385660C-61AC-43E8-B244-B0A97C9A0BF5Q42634251-5B18AE98-C856-415F-9E56-CEA22D002068Q47226789-EB3D2538-4E64-43CD-8574-9D7DEC0C38C5Q47710528-B326F552-9C97-43DB-91A2-2BB826F6235DQ48109260-ACC3DD9E-0CC5-46B0-9F02-A8798AF602A8Q48275060-BA63C005-EE1D-4EF4-87CF-682D5BE2BAA8Q48631039-CF918747-2413-4EEB-A2D6-1B66489ED0B8Q48651339-490496E8-5DFA-49B0-B7E0-8D667D449014Q49853776-E30009B0-A4EE-47D2-99E9-43A0B03BF08DQ51127942-E135F807-71DF-465C-B9EB-BD1682D4746FQ52860267-C57AC79F-3F9D-48CE-9266-D5333A775E48Q53024366-B73D41E2-E9B6-4F1B-A6BE-113EE6207692Q54248636-B6BA0AC8-3621-4B56-B1FA-2D56A5F1BF8EQ54747693-CCFF16B1-D350-471B-B972-BD9399B48192Q58797073-CA679C4A-2151-4AD9-94B4-7E9CDB744F59Q58802129-BBF8DC97-24C0-4B92-A723-45814156AF5C
P2860
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Prophylactic central compartme ...... lled single institution study.
@en
Prophylactic central compartme ...... lled single institution study.
@nl
type
label
Prophylactic central compartme ...... lled single institution study.
@en
Prophylactic central compartme ...... lled single institution study.
@nl
prefLabel
Prophylactic central compartme ...... lled single institution study.
@en
Prophylactic central compartme ...... lled single institution study.
@nl
P2093
P50
P356
P1476
Prophylactic central compartme ...... lled single institution study.
@en
P2093
E Molinaro
G Materazzi
L Torregrossa
S Sellari-Franceschini
P304
P356
10.1210/JC.2014-3825
P407
P577
2015-01-15T00:00:00Z